Study2020

Gelatin hydrogels with eicosapentaenoic acid can prevent osteoarthritis progression in vivo in a mouse model

Tsubosaka M, Kihara S, Hayashi S, Nagata J, Kuwahara T, Fujita M, Kikuchi K, Takashima Y, Kamenaga T, Kuroda Y, Takeuchi K, Fukuda K, Takayama K, Hashimoto S, Matsumoto T, Niikura T, Tabata Y, Kuroda R

Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 22 citations

How it was studied

Design
Animal study (classified by our AI screen)
Studied in
Animals
Main outcome
Health markers and function

Who paid for it

Funding
Independent funding
Government
Japan Society for the Promotion of Science
Grants
Japan Society for the Promotion of Science (18K09105); Japan Society for the Promotion of Science (20K09147)

Based on 1 listed funder(s).

Publication

Published
2020-04-09 · J Orthop Res · vol. 38 · issue 10 · pp. 2157–2169
Publisher
Wiley
Cited
31 citations · more than 89% of similar papers · 2.4× the field average
References
42 works
Access
Open access (repository copy)
Research areas
Osteoarthritis Treatment and Mechanisms · Inflammatory mediators and NSAID effects · Veterinary Equine Medical Research
Keywords
Eicosapentaenoic acid, Gelatin, Self-healing hydrogels, Chemistry, In vivo, Corn oil, Osteoarthritis, Polyunsaturated fatty acid, Hyaluronic acid, Pharmacology, Medicine, Fatty acid, Biochemistry, Pathology, Food science, Biology, Biotechnology, Anatomy
MeSH
cartilage, articular, animals, mice, inbred c57bl, humans, osteoarthritis, synovitis, disease progression, eicosapentaenoic acid, gelatin, hydrogels, random allocation, drug evaluation, preclinical, micelles, male, primary cell culture, biomarkers

18 authors

From JP

  • Masanori TsubosakaKobe University
  • Shinsuke KiharaKobe University
  • Shinya Hayashi · correspondingKobe University
  • Junpei NagataKyoto University
  • Toshie KuwaharaKyoto University
  • Masahiro FujitaKobe University

Abstract

Eicosapentanoic acid (EPA) is an antioxidant and omega-3 polyunsaturated fatty acid that reduces inflammatory cytokine production. Gelatin hydrogel can be used as a carrier of a physiologically active substance that release it gradually for an average of ~3 weeks. Therefore, this study aimed to clarify the effect of EPA-incorporating gelatin hydrogels on osteoarthritis (OA) progression in vivo. Ten-week-old male C57BL/6J mice were randomly divided into six groups (n = 6): Sham, destabilization of the medial meniscus (DMM), Corn: DMM + 2 µL corn oil, EPA injection alone (EPA-I): DMM + 2 µL corn oil + 125 μg/μL EPA, Gel: DMM + gelatin hydrogels, and EPA-G: DMM + 125 μg/μL EPA-incorporating gelatin hydrogels. The mice were euthanized at 8 weeks after DMM or Sham surgery, and subjected to histological evaluation. Matrix-metalloproteinases-3 (MMP-3), MMP-13, interleukin-1β (IL-1β), p-IKK α/β, CD86, and CD163 protein expression in the synovial cartilage was detected by immunohistochemical staining. F4/80 expression was also assessed using the F4/80 score of macrophage. Histological score was significantly lower in EPA-G than in EPA-I. MMP-3-, MMP-13-, IL-1β-, and p-IKK α/β-positive cell ratio was significantly lower in EPA-G than in EPA-I. However, CD86- and CD163-positive cell ratio was not significantly different between EPA-I and EPA-G. The average-sum F4/80 score of macrophage in EPA-G was significantly lower than that in EPA-I. EPA-incorporating gelatin hydrogels were shown to prevent OA progression in vivo more effectively than EPA injection alone. Our results suggested that intra-articular administration of controlled-release EPA can be a new therapeutic approach for treating OA.

Abstract via Europe PMC. Copyright remains with the authors or publisher.

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.